Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.00
-1.10 (-1.55%)
Aug 12, 2025, 12:42 PM CST
-1.55%
Market Cap3.54B
Revenue (ttm)n/a
Net Income (ttm)-118.89M
Shares Out49.80M
EPS (ttm)-2.39
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,549
Average Volume76,004
Open71.40
Previous Close71.10
Day's Range69.10 - 71.40
52-Week Range57.00 - 77.30
Beta-0.08
RSI55.10
Earnings DateAug 8, 2025

About Paramount Global

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.